Activated TPH and CD8+ T cell frequencies were significantly increased in patients with active AIH compared to remission AIH or NASH (TPH: 0.88% of total CD3+ vs. This evidence concerns the gene CD8A and metabolic dysfunction-associated steatohepatitis.